Overview: Wegovy enters a new era as an oral GLP-1 option The obesity treatment landscape is changing again as Novo Nordisk’s Wegovy® becomes broadly available in an oral tablet form for adults in the United States. This marks the first and only oral glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management, offering a convenient…